Effect of vitamin B6 on pain, disease severity, and psychological profile of fibromyalgia patients; a randomized, double-blinded clinical trial

被引:4
作者
Ghavidel-Parsa, Banafsheh [1 ]
Naeimi, Arvin [2 ]
Gharibpoor, Faeze [2 ]
Sattari, Nazila [2 ]
Jafari, Atefeh [3 ]
Masooleh, Irandokht Shenavar [1 ]
Montazeri, Ali [4 ]
机构
[1] Guilan Univ Med Sci, Sch Med, Razi Hosp, Rheumatol Res Ctr, Rasht, Iran
[2] Guilan Univ Med Sci, Deputy Res & Technol, Student Res Comm, Namjoo St, Rasht 4144666949, Guilan, Iran
[3] Guilan Univ Med Sci, Sch Pharm, Dept Clin Pharm, Rasht, Iran
[4] ACECR, Iranian Inst Hlth Sci Res, Hlth Metr Res Ctr, Populat Hlth Res Grp, Tehran, Iran
关键词
Fibromyalgia; Pain; Vitamin B6; Pyridoxine; SUPPLEMENTATION; DEPRESSION;
D O I
10.1186/s12891-022-05637-7
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Given the role of vitamin B6 on pronociceptive/antinociceptive neurotransmitters balance, metabolic reactions, and inflammation, it is important to clarify the effect of vitamin B6 on pain and psychological disturbance in fibromyalgia (FM). This study aimed to evaluate whether an 80-mg daily dose of vitamin B6 improves pain, disease severity and psychological symptoms of FM compared to a placebo. Methods: This randomized, double-blinded, placebo-controlled trial was performed on the FM patients whose diagnosis was confirmed by a rheumatologist based on the 2016 American College of Rheumatology (ACR). 90 Patients were randomized to receive either vitamin B6 (80 mg daily) or placebo in a 1:1 ratio, with a permuted block size of 30 stratified by disease severity. Primary outcomes included the Revised Fibromyalgia Impact Questionnaire (FIQR), Hospital Anxiety and Depression Scale (HADS), 12-item short-form health survey (SF-12), and pain visual analog scale (pain-VAS)). The mean differences in outcomes (before and after treatment) were compared between the vitamin B6 and placebo groups using an independent T-test. An ANCOVA model adjusted for baseline outcome value was also provided to compare the outcomes between the two groups. Results: Of 90 eligible patients, 60 patients (31 patients in vitamin B6 and 29 in the placebo group) completed the trial. Overall, the FIQR, pain-VAS, and HADS-anxiety scores improved after treatment in both vitamin B6 and placebo groups; However, there was no statistically significant intergroup difference regarding primary outcomes. ANCOVA model also showed no difference in the treatment effects. Conclusions: Our results showed no priority for vitamin B6 over placebo in FM patients. Considering the potential ameliorating role of vitamin B6 on pain and psychological symptoms, acknowledgment of vitamin B6 as a relatively safe adjuvant treatment needs larger future studies.
引用
收藏
页数:9
相关论文
共 33 条
[1]  
Akaltun MS, 2019, Annals of Medical Research, V26, P1943, DOI DOI 10.5455/ANNALSMEDRES.2019.05.273
[2]   Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia [J].
Akturk, Semra ;
Buyukavci, Raikan .
CLINICAL RHEUMATOLOGY, 2017, 36 (08) :1885-1889
[3]   Correlation of hematological indices and ratios derived from them with FIQR scores in fibromyalgia [J].
Al-Nimer, Marwan Salih Mohammud ;
Mohammad, Tatar Ahmad Merza .
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2018, 34 (05) :1219-1224
[4]   B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin [J].
Alberto Calderon-Ospina, Carlos ;
Orlando Nava-Mesa, Mauricio .
CNS NEUROSCIENCE & THERAPEUTICS, 2020, 26 (01) :5-13
[5]  
Aufiero E, 2004, NUTR REV, V62, P96, DOI 10.1111/j.1753-4887.2004.tb00030.x
[6]   The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties [J].
Bennett, Robert M. ;
Friend, Ronald ;
Jones, Kim D. ;
Ward, Rachel ;
Han, Bobby K. ;
Ross, Rebecca L. .
ARTHRITIS RESEARCH & THERAPY, 2009, 11 (04)
[7]   Vitamin B6 prevents excessive inflammation by reducing accumulation of sphingosine-1-phosphate in a sphingosine-1-phosphate lyase-dependent manner [J].
Du, Xialin ;
Yang, Yalong ;
Zhan, Xiaoxia ;
Huang, Yulan ;
Fu, Yuling ;
Zhang, Zelin ;
Liu, Honglin ;
Zhang, Lijie ;
Li, Yanfen ;
Wen, Qian ;
Zhou, Xinying ;
Zuo, Daming ;
Zhou, Chaoying ;
Li, Laisheng ;
Hu, Shengfeng ;
Ma, Li .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (22) :13129-13138
[8]   Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses [J].
Faul, Franz ;
Erdfelder, Edgar ;
Buchner, Axel ;
Lang, Albert-Georg .
BEHAVIOR RESEARCH METHODS, 2009, 41 (04) :1149-1160
[9]   Unravelling Fibromyalgia-Steps Toward Individualized Management [J].
Haeuser, Winfried ;
Perrot, Serge ;
Clauw, Daniel J. ;
Fitzcharles, Mary-Ann .
JOURNAL OF PAIN, 2018, 19 (02) :125-134
[10]   The neurobiology of central sensitization [J].
Harte, Steven E. ;
Harris, Richard E. ;
Clauw, Daniel J. .
JOURNAL OF APPLIED BIOBEHAVIORAL RESEARCH, 2018, 23 (02)